Express Pharma - Page 375 of 1139 - Express Pharma

Lonza Capsugel celebrates 25 years of its category-defining joint health solution: UC-II® undenatured type II collagen

Leiutis marks milestone with CDSCO approval for Synthetic Cannabidiol Oral Solution for mild to moderate anxiety disorders

Express Pharma CPHI

Pfizer drug from Medivation deal shows promise in breast cancer: Study

Keytruda improves survival for bladder cancer patients

Celgene leukaemia drug extends survival in early stage trial

Weight loss tied to lower risk of knee joint degeneration

Bristol-Myers NASH drug reduces liver fat in midstage study

Eating tree nuts may cut risk that colon cancer will return: Study

First-in-class innovation a key strategy for pharma companies in a harsh market environment: GBI Research

Haematological cancers pharma pipeline one of the strongest within oncology: GBI Research

Global immunology market to surpass $75 bn by 2022 despite patent expirations

Growth hormone deficiency market to grow steadily, surpassing $2 bn by 2026